Germline mutations in the BLM gene in humans give rise to Bloom’s syndrome (BS), an autosomal recessive condition characterized by pre- and post-natal growth retardation, microcephaly, skin pigmentation abnormalities, and a strong predisposition to the development of cancer (Cunniff et al, 2017; Ellis et al, 1995). The gene discussed is BLM; the disease is cancer.